Amalgamated Financial’s Inspire Medical Systems INSP Stock Holding History

Amalgamated Financial’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.12M	Buy	+4,370	New	+$999K	0.01%	1120

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Amalgamated Financial's INSP Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Inspire Medical Systems (INSP) in Q1 2022: 4,370 shares worth $1.12M. The stake represents 0.01% of the portfolio and ranks #1120 among its holdings.

299 funds tracked by Wall St. Rank hold INSP as of Q1 2022.

Amalgamated Financial held 4,370 shares of Inspire Medical Systems worth $1.12M as of Q1 2022.
Inspire Medical Systems was a new Amalgamated Financial position in Q1 2022.
Inspire Medical Systems made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1120 holding.
299 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.